https://www.selleckchem.com/products/at13387.html
Molecular classification of breast cancer is an important factor for prognostic and clinical outcomes. There are no data regarding molecular breast cancer subtypes among Togolese women. The objective of this study was to evaluate the expression of ER, PR, HER2, and molecular subtypes of breast cancer receptors in Togolese patients and to establish the correlation between clinical and histological data and molecular types. Clinicopathologic data of patients were collected from clinical records. Immunohistochemistry biomarkers (ER, PR, an
Like
Comment
Share
